Jane Street’s Silexion Therapeutics SLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.1K Buy
+3,020
New +$89.5K ﹤0.01% 11288

Other funds holding SLXN

Jane Street's SLXN Position: Q3 2026 in Review

Jane Street opened a new position in Silexion Therapeutics (SLXN) in Q3 2026: 3,020 shares worth $20.1K. The stake represents ﹤0.01% of the portfolio and ranks #11288 among its holdings.

7 funds tracked by Wall St. Rank hold SLXN as of Q3 2026.

  • Jane Street held 3,020 shares of Silexion Therapeutics worth $20.1K as of Q3 2026.
  • Silexion Therapeutics was a new Jane Street position in Q3 2026.
  • Silexion Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #11288 holding.
  • 7 funds tracked by Wall St. Rank held Silexion Therapeutics as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.